DrugPatentWatch Database Preview

Emd Serono Company Profile

« Back to Dashboard

What is the competitive landscape for EMD SERONO, and when can generic versions of EMD SERONO drugs launch?

EMD SERONO has thirteen approved drugs.

There are five US patents protecting EMD SERONO drugs.

There are one hundred and four patent family members on EMD SERONO drugs in thirty-nine countries and twelve supplementary protection certificates in six countries.

Summary for Emd Serono

International Patents:	104
US Patents:	5
Tradenames:	13
Ingredients:	8
NDAs:	13

Drugs and US Patents for Emd Serono

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emd Serono	GONAL-F RFF REDI-JECT	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021684-002	May 25, 2004		RX	Yes	Yes	7,741,268		Y
Emd Serono	SEROSTIM	somatropin recombinant	INJECTABLE;INJECTION	020604-003	Jul 25, 1997		RX	No	No
Emd Serono	SAIZEN	somatropin recombinant	INJECTABLE;INJECTION	019764-003	Aug 29, 2000		RX	Yes	Yes
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-002	Sep 29, 1997		DISCN	No	No
Emd Serono	SAIZEN	somatropin recombinant	INJECTABLE;INJECTION	019764-001	Oct 8, 1996		DISCN	No	No
Emd Serono	SEROSTIM	somatropin recombinant	INJECTABLE;INJECTION	020604-002	Aug 23, 1996	BX	RX	No	No
Emd Serono	GONAL-F RFF	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021765-002	Mar 25, 2004		RX	Yes	Yes

Expired US Patents for Emd Serono

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emd Serono	GONAL-F RFF REDI-JECT	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021684-001	May 25, 2004	5,767,251
Emd Serono	GONAL-F RFF REDI-JECT	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021684-003	May 25, 2004	5,767,251
Emd Serono	NOVANTRONE	mitoxantrone hydrochloride	INJECTABLE;INJECTION	019297-002	Dec 23, 1987	4,820,738
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-002	Sep 29, 1997	4,589,402
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-005	Mar 26, 2004	5,767,251
Emd Serono	GEREF	sermorelin acetate	INJECTABLE;INJECTION	019863-001	Dec 28, 1990	4,517,181
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-003	May 25, 2000	5,767,251

International Patents for Emd Serono Drugs

Country	Patent Number	Estimated Expiration
South Africa	200100190
Denmark	0814841
Norway	20010326
Slovenia	1082129
Japan	4699991
Japan	2006522072
Japan	H11502205

Supplementary Protection Certificates for Emd Serono Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0853945	6/2010	Austria		PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
0853945	SPC/GB10/022	United Kingdom		PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125
0853945	10C0024	France		PRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
0853945	SZ 6/2010	Austria		PRODUCT NAME: CORIFOLLITROPIN ALFA
0299402	099C0031	Belgium		PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413
0853945	122010000011	Germany		PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
0299402	C990029	Netherlands		PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Emd Serono
• Emd Serono Inc